Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies. [electronic resource]
Producer: 20170605Description: 726-733 p. digitalISSN:- 1468-1331
- Adult
- Delayed-Action Preparations
- Dimethyl Fumarate -- administration & dosage
- Disease Progression
- Female
- Glatiramer Acetate -- administration & dosage
- Humans
- Immunosuppressive Agents -- administration & dosage
- Magnetic Resonance Imaging -- methods
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- diagnostic imaging
- Recurrence
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.